Ernexa Therapeutics Inc. short interest in 2026
In 2026, Ernexa Therapeutics Inc.'s disclosed short interest ran from 1.76% of shares outstanding on 15 Jan 2026 to 0.88% on 15 Sep 2026, a change of -0.88 percentage points. The year's high was 3.15% on 27 Feb 2026 and its low 0.32% on 13 Mar 2026, averaging 1.23% across 11 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.00 days on 15 Jan 2026. Full history: Ernexa Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 1.76% (15 Jan 2026)
- End of year
- 0.88% (15 Sep 2026)
- Change
- -0.88 pp
- High
- 3.15% (27 Feb 2026)
- Low
- 0.32% (13 Mar 2026)
- Average
- 1.23%
- Highest days to cover
- 1.00 (15 Jan 2026)
- SEC filings marked
- 3
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 1.76% | 1.00 | |
| 30 Jan 2026 | 1.71% | 1.00 | |
| 13 Feb 2026 | 1.33% | 1.00 | |
| 27 Feb 2026 | 3.15% | 1.00 | |
| 13 Mar 2026 | 0.32% | 1.00 | 10-K filed |
| 31 Mar 2026 | 0.55% | 1.00 | |
| 15 Apr 2026 | 0.69% | 1.00 | |
| 30 Apr 2026 | 0.46% | 1.00 | |
| 14 Aug 2026 | 1.51% | 1.00 | 10-Q filed, 10-Q filed |
| 31 Aug 2026 | 1.21% | 1.00 | |
| 15 Sep 2026 | 0.88% | 1.00 |
See also: Ernexa Therapeutics Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.